Bio-Techne Corporation
US ˙ NasdaqGS ˙ US09073M1045

SecurityTECH / Bio-Techne Corporation
InstitutionStephens Inc /ar/
Latest Disclosed Ownership12,422 shares
Latest Disclosed Value $ 649,174
Stephens Inc /ar/ reports 34.35% increase in ownership of TECH / Bio-Techne Corporation

On April 28, 2026 - Stephens Inc /ar/ filed a 13F-HR form disclosing ownership of 12,422 shares of Bio-Techne Corporation (US:TECH) valued at $649,174 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 9,246 shares of Bio-Techne Corporation. This represents a change in shares of 34.35% during the quarter. The current value of the position is $631,659 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F BIO-TECHNE COM 09073M104 12,422 3,176 34.35 649 19.52 0.0081
2026-02-05 2025-12-31 13F BIO-TECHNE COM 09073M104 9,246 824 9.78 544 16.03 0.0068
2025-10-27 2025-09-30 13F BIO-TECHNE COM 09073M104 8,422 273 3.35 469 11.69 0.0060
2025-07-29 2025-06-30 13F BIO-TECHNE COM 09073M104 8,149 367 4.72 419 -8.11 0.0058
2025-05-01 2025-03-31 13F BIO-TECHNE COM 09073M104 7,782 -1,064 -12.03 456 -28.41 0.0067
2025-01-28 2024-12-31 13F BIO-TECHNE COM 09073M104 8,846 1,834 26.16 637 13.75 0.0089
2024-10-28 2024-09-30 13F BIO-TECHNE COM 09073M104 7,012 217 3.19 560 15.23 0.0080
2024-08-06 2024-06-30 13F BIO-TECHNE COM 09073M104 6,795 17 0.25 487 1.89 0.0074
2024-05-15 2024-03-31 13F BIO-TECHNE COM 09073M104 6,778 -85 -1.24 477 -9.83 0.0074
2024-02-13 2023-12-31 13F BIO-TECHNE COM 09073M104 6,863 -502 -6.82 530 5.59 0.0091
2023-11-14 2023-09-30 13F BIO-TECHNE COM 09073M104 7,365 -124 -1.66 501 -18.00 0.0096
2023-08-14 2023-06-30 13F BIO-TECHNE COM 09073M104 7,489 750 11.13 611 22.44 0.0110
2023-05-15 2023-03-31 13F BIO-TECHNE COM 09073M104 6,739 131 1.98 500 -8.78 0.0096
2023-02-14 2022-12-31 13F/A-1 BIO-TECHNE COM 09073M104 6,608 5,417 454.83 548 61.83 0.0112
2023-01-25 2022-12-31 13F BIO-TECHNE OM 09073M104 6,608 5,417 1 0.0112
2022-11-02 2022-09-30 13F BIO-TECHNE OM 09073M104 1,191 -18 -1.49 338 -19.33 0.0072
2022-08-03 2022-06-30 13F BIO-TECHNE OM 09073M104 1,209 -56 -4.43 419 -23.54 0.0085
2022-05-04 2022-03-31 13F BIO-TECHNE OM 09073M104 1,265 41 3.35 548 -13.43 0.0089
2022-03-07 2021-12-31 13F BIO-TECHNE OM 09073M104 1,224 91 8.03 633 15.30 0.0096
2021-10-27 2021-09-30 13F BIO-TECHNE COM 09073M104 1,133 90 8.63 549 16.81 0.0085
2021-08-12 2021-06-30 13F BIO-TECHNE COM 09073M104 1,043 77 7.97 470 27.37 0.0070
2021-05-14 2021-03-31 13F BIO-TECHNE COM 09073M104 966 -496 -33.93 369 -20.47 0.0061
2021-02-10 2020-12-31 13F BIO-TECHNE COM 09073M104 1,462 100 7.34 464 37.69 0.0083
2020-11-13 2020-09-30 13F BIO-TECHNE COM 09073M104 1,362 530 63.70 337 53.18 0.0066
2020-08-24 2020-06-30 13F BIO-TECHNE COM 09073M104 832 1 0.12 220 39.24 0.0047
2020-05-14 2020-03-31 13F BIO-TECHNE COM 09073M104 831 13 1.59 158 -12.22 0.0042
2020-02-14 2019-12-31 13F BIO TECHNE COM 09073M104 818 -1,034 -55.83 180 -50.28 0.0038
2019-10-18 2019-09-30 13F BIO TECHNE COM 09073M104 1,852 17 0.93 362 -5.48 0.0080
2019-08-01 2019-06-30 13F BIO TECHNE COM 09073M104 1,835 -151 -7.60 383 -2.79 0.0087
2019-05-03 2019-03-31 13F BIO TECHNE COM 09073M104 1,986 36 1.85 394 39.72 0.0093
2019-02-11 2018-12-31 13F BIO TECHNE COM 09073M104 1,950 -478 -19.69 282 -43.15 0.0080
2018-11-14 2018-09-30 13F BIO TECHNE COM 09073M104 2,428 322 15.29 496 58.97 0.0123
2018-08-10 2018-06-30 13F BIO TECHNE COM 09073M104 2,106 139 7.07 312 5.05 0.0094
2018-05-03 2018-03-31 13F BIO TECHNE COM 09073M104 1,967 1,511 331.36 297 403.39 0.0111
2018-02-05 2017-12-31 13F BIO TECHNE COM 09073M104 456 49 12.04 59 20.41 0.0022
2017-11-08 2017-09-30 13F BIO TECHNE COM 09073M104 407 407 49 0.0018
2015-02-12 2014-12-31 13F TECHNE COM 878377100 0 -129 -100.00 0 -100.00
2014-11-14 2014-09-30 13F TECHNE COM 878377100 129 0 0.00 12 0.00 0.0006
2014-08-15 2014-06-30 13F TECHNE COM 878377100 129 -6 -4.44 12 0.00 0.0006
2014-05-13 2014-03-31 13F TECHNE COM 878377100 135 -2,762 -95.34 12 -95.62 0.0007
2014-02-14 2013-12-31 13F TECHNE COM 878377100 2,897 425 17.19 274 38.38 0.0136
2013-11-06 2013-09-30 13F TECHNE COM 878377100 2,472 -15 -0.60 198 15.12 0.0107
2013-08-12 2013-06-30 13F TECHNE COM 878377100 2,487 2,487 172 0.0096
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.